Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Piñol-Ripoll

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Sleep Medicine|March 22, 2019
The STOP-Bang and Berlin questionnaires to identify obstructive sleep apnoea in Alzheimer's disease patientsCarme Jorge, Ivan Benítez, Gerard Torres, et al.
Molecular Neurobiology|July 29, 2020
Circulating MicroRNA Profile Associated with Obstructive Sleep Apnea in Alzheimer's DiseaseA Targa, F Dakterzada, I D Benítez, et al.
Frontiers in Aging Neuroscience|September 9, 2021
Reduced Levels of miR-342-5p in Plasma Are Associated With Worse Cognitive Evolution in Patients With Mild Alzheimer's DiseaseFarida Dakterzada, Iván David Benítez, Adriano Targa, et al.
Journal of Neurology|December 14, 2019
Prevalence of obstructive sleep apnea in Alzheimer's disease patientsAnna Michela Gaeta, Ivan D Benítez, Carmen Jorge, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 2, 2021
Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR studyMercè Boada, Oscar L López, Javier Olazarán, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 8, 2025
Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 studyMaría Pascual-Lucas, Ana María Lacosta, María Montañés, et al.
The European Respiratory Journal|June 20, 2020
Obstructive sleep apnoea and cognitive decline in mild-to-moderate Alzheimer's diseaseCarmen Jorge, Adriano Targa, Iván David Benítez, et al.
Brain Communications|August 16, 2021
Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progressionJoaquim Sol, Mariona Jové, Monica Povedano, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 29, 2023
Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter studyNúria Guillén, José Contador, Mariateresa Buongiorno, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 28, 2020
A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR StudyMercè Boada, Oscar L López, Javier Olazarán, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Sleep Medicine|March 22, 2019
The STOP-Bang and Berlin questionnaires to identify obstructive sleep apnoea in Alzheimer's disease patientsCarme Jorge, Ivan Benítez, Gerard Torres, et al.
Molecular Neurobiology|July 29, 2020
Circulating MicroRNA Profile Associated with Obstructive Sleep Apnea in Alzheimer's DiseaseA Targa, F Dakterzada, I D Benítez, et al.
Frontiers in Aging Neuroscience|September 9, 2021
Reduced Levels of miR-342-5p in Plasma Are Associated With Worse Cognitive Evolution in Patients With Mild Alzheimer's DiseaseFarida Dakterzada, Iván David Benítez, Adriano Targa, et al.
Journal of Neurology|December 14, 2019
Prevalence of obstructive sleep apnea in Alzheimer's disease patientsAnna Michela Gaeta, Ivan D Benítez, Carmen Jorge, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 2, 2021
Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR studyMercè Boada, Oscar L López, Javier Olazarán, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 8, 2025
Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 studyMaría Pascual-Lucas, Ana María Lacosta, María Montañés, et al.
The European Respiratory Journal|June 20, 2020
Obstructive sleep apnoea and cognitive decline in mild-to-moderate Alzheimer's diseaseCarmen Jorge, Adriano Targa, Iván David Benítez, et al.
Brain Communications|August 16, 2021
Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progressionJoaquim Sol, Mariona Jové, Monica Povedano, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 29, 2023
Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter studyNúria Guillén, José Contador, Mariateresa Buongiorno, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 28, 2020
A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR StudyMercè Boada, Oscar L López, Javier Olazarán, et al.
Pageof 11